Abstract
Abstract

Background and Purpose
Lifestyle is closely related to major depressive disorder (MDD). Given the growing focus on the impact of diet on mental health, this study examined how dietary habits affect the pathophysiology of MDD.


Experimental Approach
Health check‐up data were analysed. Mice received sucrose under chronic unpredictable mild stress (CUMS) and were evaluated by behavioural, neurochemical and metabolic analysis.


Key Results

Health check‐up data showed increased sucrose intake in MDD patients. When mice received sucrose under CUMS, hyperactivity and aggression were attenuated, although social deficits or behavioural despair induced by CUMS persisted, and recognition memory was impaired. The behavioural changes were associated with dysfunction of the locus coeruleus‐prefrontal cortex circuit, caused by impaired noradrenaline release due to presynaptic
α
2
‐adrenoceptor upregulation, and postsynaptic
α
1
‐adrenoceptor and
β
1
‐adrenoceptor downregulation.
α
2
‐Adrenoceptor antagonism by atipamezole rescued behavioural changes induced by sucrose intake under CUMS, whereas
α
2
‐adrenoceptor agonism by guanfacine in CUMS mice mimicked these behavioural changes. Among the antidepressants, mirtazapine effectively increased noradrenaline release and rescued behavioural changes induced by sucrose intake under CUMS. Sucrose intake under CUMS induced peripheral hyperglycaemia and dysregulation of central glucose metabolism. Glucose transporter inhibition by phloretin rescued behavioural changes induced by sucrose intake under CUMS. Intracerebroventricular and systemic streptozotocin administration reproduced these behavioural changes and
α
2
‐adrenoceptor upregulation.



Conclusions and Implications

Our findings suggest that the observed behavioural changes are associated with dysfunction of the noradrenergic
α
2
‐adrenoceptor system induced by impaired glucose metabolism. These insights targeting the noradrenergic‐metabolic axis might be a new strategy for sugar‐induced depression subtypes.
Topics

No keywords indexed for this article. Browse by subject →

References
86
[4]
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes

Stephen P. H. Alexander, Doriano Fabbro, Eamonn Kelly et al.

British Journal of Pharmacology 10.1111/bph.16181
[8]
Chronic unpredictable mild stress for modeling depression in rodents: Meta-analysis of model reliability

Svitlana Antoniuk, M. Bijata, Evgeni Ponimaskin et al.

Neuroscience & Biobehavioral Reviews 10.1016/j.neubiorev.2018.12.002
[18]
Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene

Avshalom Caspi, Karen Sugden, Terrie E. Moffitt et al.

Science 10.1126/science.1083968
[38]
A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial)

Felice N. Jacka, Adrienne O’Neil, Rachelle Opie et al.

BMC Medicine 10.1186/s12916-017-0791-y
[43]
Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome

Yoshinaga Kawano, Madeline Edwards, Yiming Huang et al.

Cell 10.1016/j.cell.2022.08.005
[48]
Major depressive disorder on a neuromorphic continuum

Zhiliang Long, Gong-Jun Ji, Shaoqiang Han et al.

Nature Communications 10.1038/s41467-025-57682-0

Showing 50 of 86 references

Metrics
0
Citations
86
References
Details
Published
Dec 21, 2025
Vol/Issue
183(9)
Pages
2099-2122
License
View
Authors
Funding
Takeda Science Foundation
Smoking Research Foundation
Cite This Article
Takatoshi Sakata, Kazuo Kunisawa, Masaya Hasegawa, et al. (2025). Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes. British Journal of Pharmacology, 183(9), 2099-2122. https://doi.org/10.1111/bph.70288
Related

You May Also Like